Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 991 AL 1005

Alzheimer's and Parkinson's diseases: an environmental proteomic point of view

Demartini DR, Schilling LP, da Costa JC, Carlini CR.

J Proteomics. 2014 Jun 2;104:24-36. doi: 10.1016/j.jprot.2014.04.014. Epub 2014 Apr 18.

Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Watts NB; GLOW investigators.

Nat Rev Endocrinol. 2014 Jul;10(7):412-22. doi: 10.1038/nrendo.2014.55. Epub 2014 Apr 22.

The many faces of impaired bladder emptying

Andersson KE.

Curr Opin Urol. 2014 Jul;24(4):363-9. doi: 10.1097/MOU.0000000000000059.

The glutathione system: a new drug target in neuroimmune disorders

Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, Maes M.

Mol Neurobiol. 2014 Dec;50(3):1059-84. doi: 10.1007/s12035-014-8705-x. Epub 2014 Apr 22.

DBS for Parkinson's disease in a HIV-positive patient: long-term follow-up

Penner F, Messina G, Rizzi M, Franzini A.

Acta Neurochir (Wien). 2014 Aug;156(8):1513-4. doi: 10.1007/s00701-014-2091-z. Epub 2014 Apr 22.

Knowledge and attitudes about Parkinson's disease among a diverse group of older adults

Pan S, Stutzbach J, Reichwein S, Lee BK, Dahodwala N.

J Cross Cult Gerontol. 2014 Sep;29(3):339-52. doi: 10.1007/s10823-014-9233-x.

Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease

Joers V, Emborg ME.

Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):125-59. eCollection 2014.

You're the flight surgeon: Wolff-Parkinson-White

Miller DC.

Aviat Space Environ Med. 2014 Apr;85(4):487-9. doi: 10.3357/asem.3694.2014.

Screening and assessment tools for determining fitness to drive: a review of the literature for the pathways project

Dickerson AE.

Occup Ther Health Care. 2014 Apr;28(2):82-121. doi: 10.3109/07380577.2014.904535.

Consensus statements on driving in people with Parkinson's disease

Classen S; National Highway Traffic Safety Administration; American Occupational Therapy Association.

Occup Ther Health Care. 2014 Apr;28(2):140-7. doi: 10.3109/07380577.2014.890307.

Harm avoidance is associated with progression of parkinsonism in community-dwelling older adults: a prospective cohort study

Buchman AS, Yu L, Wilson RS, Shulman JM, Boyle PA, Bennett DA.

BMC Geriatr. 2014 Apr 23;14:54. doi: 10.1186/1471-2318-14-54.

Rating scales and questionnaires for assessment of sleep disorders in Parkinson's disease: what they inform about?

Zea-Sevilla MA, Martínez-Martín P.

J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S33-40. doi: 10.1007/s00702-014-1217-z. Epub 2014 Apr 23.

Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes

Alcalay RN, Dinur T, Quinn T, Sakanaka K, Levy O, Waters C, Fahn S, Dorovski T, Chung WK, Pauciulo M, Nichols W, Rana HQ, Balwani M, Bier L, Elstein D, Zimran A.

JAMA Neurol. 2014 Jun;71(6):752-7. doi: 10.1001/jamaneurol.2014.313.

Early versus delayed initiation of pharmacotherapy in Parkinson's disease

Löhle M, Ramberg CJ, Reichmann H, Schapira AH.

Drugs. 2014 Apr;74(6):645-57. doi: 10.1007/s40265-014-0209-5.

Pharmacological treatment of Parkinson disease: a review

Connolly BS, Lang AE.

JAMA. 2014 Apr 23-30;311(16):1670-83. doi: 10.1001/jama.2014.3654.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias